MRIGlobal has won a 10-year contract to help develop and test drug ingredients for eventual use in human clinical trials. The contract was awarded to the Kansas City research institute through the National Institute of Neurological Disorders and Stroke.
MRIGlobal has won a 10-year contract to help develop and test drug ingredients for eventual use in human clinical trials. The contract was awarded to the Kansas City research institute through the National Institute of Neurological Disorders and Stroke. File photo The Kansas City Star
MRIGlobal has won a 10-year contract to help develop and test drug ingredients for eventual use in human clinical trials. The contract was awarded to the Kansas City research institute through the National Institute of Neurological Disorders and Stroke. File photo The Kansas City Star

Business

MRIGlobal wins $54 million contract from the National Institutes of Health

January 15, 2015 6:14 PM

  Comments  

Videos